BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37347577)

  • 1. Decentralized Clinical Trials: Potentials for Equity in Digital Health.
    Weber D; Nøhr C
    Stud Health Technol Inform; 2023 Jun; 304():91-95. PubMed ID: 37347577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access.
    Underhill C; Freeman J; Dixon J; Buzza M; Long D; Burbury K; Sabesan S; McBurnie J; Woollett A
    JAMA Oncol; 2024 Apr; 10(4):526-530. PubMed ID: 38358756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Equity and Decentralized Trials.
    Dahne J; Hawk LW
    JAMA; 2023 Jun; 329(23):2013-2014. PubMed ID: 37261810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Health Equity and COVID-19: The Innovation Curve Cannot Reinforce the Social Gradient of Health.
    Crawford A; Serhal E
    J Med Internet Res; 2020 Jun; 22(6):e19361. PubMed ID: 32452816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards digital health equity - a qualitative study of the challenges experienced by vulnerable groups in using digital health services in the COVID-19 era.
    Kaihlanen AM; Virtanen L; Buchert U; Safarov N; Valkonen P; Hietapakka L; Hörhammer I; Kujala S; Kouvonen A; Heponiemi T
    BMC Health Serv Res; 2022 Feb; 22(1):188. PubMed ID: 35151302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing Health Care Equity to Diverse and Underserved Populations in Sleep Medicine and Research Through a Digital Health Equity Framework.
    Blanc J; Hahn K; Oliveira B; Phillips R; Duthely LM; Francois L; Carrasco M; Moore J; Sternberg CA; Jean-Louis G; Seixas AA
    Sleep Med Clin; 2023 Sep; 18(3):255-267. PubMed ID: 37532367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health equity related challenges and experiences during the rapid implementation of virtual care during COVID-19: a multiple case study.
    Shahid S; Hogeveen S; Sky P; Chandra S; Budhwani S; de Silva R; Bhatia RS; Seto E; Shaw J
    Int J Equity Health; 2023 Mar; 22(1):44. PubMed ID: 36906566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decentralized clinical trials (DCTs): A few ethical considerations.
    Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
    Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing asthma research and improving health equity through decentralized clinical trials (DCTs) and mHealth technology.
    Hunt ER; Hantgan SL; Jariwala SP
    J Asthma; 2024 Apr; 61(4):265-270. PubMed ID: 37787433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What role can decentralized trial designs play to improve rare disease studies?
    Moore J; Goodson N; Wicks P; Reites J
    Orphanet J Rare Dis; 2022 Jun; 17(1):240. PubMed ID: 35725484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing digital health equity: Directions for behavioral and social science research.
    Jaworski BK; Webb Hooper M; Aklin WM; Jean-Francois B; Elwood WN; Belis D; Riley WT; Hunter CM
    Transl Behav Med; 2023 Apr; 13(3):132-139. PubMed ID: 36318232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.
    Park J; Huh KY; Chung WK; Yu KS
    Transl Clin Pharmacol; 2024 Mar; 32(1):41-51. PubMed ID: 38586122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health effectiveness of digital contact tracing in the COVID-19 pandemic: A systematic review of available data.
    Mazza C; Girardi D; Gentile L; Gaeta M; Signorelli C; Odone A
    Acta Biomed; 2021 Dec; 92(S6):e2021439. PubMed ID: 34889315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Dimensions of Diversity to Promote Inclusion in the Digital Era of Health Care: A Lexicon.
    Sharma Y; Saha A; Goldsack JC
    JMIR Public Health Surveill; 2024 Feb; 10():e51980. PubMed ID: 38335013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Inclusion as a Foundation for Health Equity. Comment on "Expanding Video Consultation Services at Pace and Scale in Scotland During the COVID-19 Pandemic: National Mixed Methods Case Study".
    Weatherburn C
    J Med Internet Res; 2022 Feb; 24(2):e34702. PubMed ID: 35038303
    [No Abstract]   [Full Text] [Related]  

  • 17. Equity in digital healthcare - the case of Denmark.
    Eriksen J; Ebbesen M; Eriksen KT; Hjermitslev C; Knudsen C; Bertelsen P; Nøhr C; Weber D
    Front Public Health; 2023; 11():1225222. PubMed ID: 37744503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and Utilization of a Postmarket Evaluation Model for Digital Contact Tracing Mobile Health Tools in the United States: Observational Cross-sectional Study.
    Cevasco KE; Roess AA
    JMIR Public Health Surveill; 2023 Mar; 9():e38633. PubMed ID: 36947135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing Health Equity in Cancer-Related Distress: Lessons Learned From the COVID-19 Pandemic on Leveraging Digital Tools and Future Directions.
    Falk D; Zebrack BJ
    J Natl Compr Canc Netw; 2022 Jul; 20(7):850-852. PubMed ID: 35830890
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics and determinants of population acceptance of COVID-19 digital contact tracing: a systematic review.
    Pegollo L; Maggioni E; Gaeta M; Odone A
    Acta Biomed; 2021 Dec; 92(S6):e2021444. PubMed ID: 34889313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.